A CASE OF HEREDITARY DISEASE IN ONE FAMILY HAVING SEVERAL CHILDREN WITH DIFFERENT BIOLOGICAL FATHERS

Download full text PDF
Issue: 
6
Year: 
2017

M. Kuznetsova, Candidate of Medical Sciences; N. Zryachkin; Yu. Tsareva; T. Elizarova V.I. Razumovsky Saratov State Medical University

Mucopolysaccharidosis type 1 (МPS 1) is included by the Ministry of Health of the Russian Federation in the list of 700 orphan diseases. The etiopathogenesis of MPS 1 is caused by mutations in the structural gene for the lysosomal enzyme α-L-iduronidase (IDUA), which is the reason for the accumulation of products of incomplete glycosaminoglycan (GAG) disintegration in the cell lysosomes. The mutations are inherited in an autosomal recessive pattern. There are currently more than 100 known mutations in the IDUA gene. Different mutations cause different clinical forms of MPS 1, such as Hurler, Hurler–Sheie, and Sheie syndromes. The polymorphism of clinical manifestations and the low incidence of MPS 1 impede its timely diagnosis and, accordingly, early initiation of therapy. The diagnosis of MPS 1 is based on the identification of the specific phenotype of patients, the determination of the urinary excretion of GAGs and their fractions, tandem mass spectrometry, and DNA diagnosis. Enzyme replacement therapy and bone marrow transplantation improve the follow-up of patients with MPS 1.

Keywords: 
genetics
orphan diseases
mucopolysaccharidosis
gargoylism
diagnosis
treatment
follow-up



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Baranova-Namazova L.S. Neobhodimo, chtoby bol'nye deti nashej strany imeli ravnyj dostup k odinakovo kachestvennoj sovremennoj meditsinskoj pomoschi // Effektivnaja farmakoterapija. – 2015; 3: 5–6.
  2. Kravchuk Zh.P., Rumjantseva O.A. Orfannye zabolevanija: opredelenie, problemy, perspektivy // Problemy zdorov'ja i ekologii. – 2013; 4: 7–11.
  3. Orfannye preparaty i redkie zabolevanija: Metodicheskie rekomendatsii / Astana, 2015; 20.
  4. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniju mukopolisaharidoza I tipa (Sindrom Gurler) / M.. 2013; 28.
  5. Materialy Mezhdunarodnoj konferentsii «Changing the Clinical Picture of MPS-I». Manchester, United Kingdom; 4-5 February, 2016.
  6. Kozlova S.I., Demikova N.S. Nasledstvennye sindromy i mediko-geneticheskoe konsul'tirovanie: atlas-spravochnik. 3-e izd. pererab. i dopoln / M.: T-vo nauchnyh izdanij KMK, Avtorskaja akademija, 2007; s. 168–9.
  7. Vijay S., Wraith J. Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I // Acta Paediatr. – 2005; 94: 872–7.
  8. Moore D., Connock M., Wraith E. et al. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK // Orphanet. J. Rare Dis. – 2008; 3: 24.
  9. Murphy A., Lambert D., Treacy E. et al. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish Republic // Arch. Dis. Child. – 2009; 94: 52–4.
  10. Mashima R., Sakai E., Kosuga M. et al. Levels of enzyme activities in six lysosomal storage diseases in Japanese neonates determined by liquid chromatography-tandem mass spectrometry // Mol. Genet. Metab. Rep. – 2016; 9: 6–11. DOI: 10.1016/j.ymgmr.2016.08.007. eCollection 2016.
  11. Postanovlenie Pravitel'stva RF ot 26.04.12 №403 (red. ot 04.09.2012) «O porjadke vedenija Federal'nogo registra lits, stradajuschih zhizneugrozhajuschimi i hronicheskimi progressirujuschimi redkimi (orfannymi) zabolevanijami, privodjaschimi k sokrascheniju prodolzhitel'nosti zhizni grazhdan ili ih invalidnosti, i ego regional'nogo segmenta» (vmeste s «Pravilami vedenija Federal'nogo registra lits stradajuschih zhizneugrozhajuschimi i hronicheskimi progressirujuschimi redkimi (orfannymi) zabolevanijami, privodjaschimi k sokrascheniju prodolzhitel'nosti zhizni grazhdan ili ih invalidnosti, i ego regional'nogo segmenta»). www.consultant.ru
  12. Federal'nyj zakon ot 21 nojabrja 2011 goda №323 «Ob osnovah ohrany zdorov'ja grazhdan v Rossijskoj Federatsii».
  13. Postanovlenie Pravitel'stva RF ot 28.11.2014 №1273 «O programme gosudarstvennyh garantij besplatnogo okazanija grazhdanam meditsinskoj pomoschi na 2015 god i na planovyj period 2016 i 2017 godov».